Filing Details

Accession Number:
0001070081-19-000059
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-12-05 16:50:57
Reporting Period:
2019-12-03
Accepted Time:
2019-12-05 16:50:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1070081 Ptc Therapeutics Inc. PTCT Pharmaceutical Preparations (2834) 043416587
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1578962 Walter Stuart Peltz C/O Ptc Therapeutics, Inc.
100 Corporate Court
South Plainfield NJ 07080
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-12-03 3,482 $50.00 18,676 No 4 S Indirect By Spouse
Common Stock Acquisiton 2019-12-03 3,900 $10.85 22,576 No 4 M Indirect By Spouse
Common Stock Disposition 2019-12-03 3,900 $50.00 18,676 No 4 S Indirect By Spouse
Common Stock Acquisiton 2019-12-03 125 $12.64 18,801 No 4 M Indirect By Spouse
Common Stock Disposition 2019-12-03 125 $50.00 18,676 No 4 S Indirect By Spouse
Common Stock Acquisiton 2019-12-03 559 $11.23 19,235 No 4 M Indirect By Spouse
Common Stock Disposition 2019-12-03 559 $50.00 18,676 No 4 S Indirect By Spouse
Common Stock Acquisiton 2019-12-03 1,000 $12.64 19,676 No 4 M Indirect By Spouse
Common Stock Disposition 2019-12-03 1,000 $50.00 18,676 No 4 S Indirect By Spouse
Common Stock Acquisiton 2019-12-03 5,741 $11.23 24,417 No 4 M Indirect By Spouse
Common Stock Disposition 2019-12-03 5,741 $50.00 18,676 No 4 S Indirect By Spouse
Common Stock Acquisiton 2019-12-03 7,656 $18.01 26,332 No 4 M Indirect By Spouse
Common Stock Disposition 2019-12-03 7,656 $50.00 18,676 No 4 S Indirect By Spouse
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Spouse
No 4 M Indirect By Spouse
No 4 S Indirect By Spouse
No 4 M Indirect By Spouse
No 4 S Indirect By Spouse
No 4 M Indirect By Spouse
No 4 S Indirect By Spouse
No 4 M Indirect By Spouse
No 4 S Indirect By Spouse
No 4 M Indirect By Spouse
No 4 S Indirect By Spouse
No 4 M Indirect By Spouse
No 4 S Indirect By Spouse
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right To Buy) Disposition 2019-12-03 3,900 $10.85 3,900 $10.85
Common Stock Stock Option (Right To Buy) Disposition 2019-12-03 125 $12.64 125 $12.64
Common Stock Stock Option (Right To Buy) Disposition 2019-12-03 559 $11.23 559 $11.23
Common Stock Stock Option (Right To Buy) Disposition 2019-12-03 1,000 $12.64 1,000 $12.64
Common Stock Stock Option (Right To Buy) Disposition 2019-12-03 5,741 $11.23 5,741 $11.23
Common Stock Stock Option (Right To Buy) Disposition 2019-12-03 7,656 $18.01 7,656 $18.01
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2023-05-15 No 4 M Indirect
1,875 2026-11-16 No 4 M Indirect
12,041 2027-01-02 No 4 M Indirect
875 2026-11-16 No 4 M Indirect
6,300 2027-01-02 No 4 M Indirect
22,969 2028-01-02 No 4 M Indirect
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (Right To Buy) $1,149.60 2020-02-02 37 37 Indirect
Common Stock Stock Option (Right To Buy) $218.40 2022-01-10 38 38 Indirect
Common Stock Stock Option (Right To Buy) $490.80 2021-04-27 58 58 Indirect
Common Stock Stock Option (Right To Buy) $30.86 2026-01-03 11,000 11,000 Indirect
Common Stock Stock Option (Right To Buy) $51.00 2025-01-02 10,880 10,880 Indirect
Common Stock Stock Option (Right To Buy) $27.05 2024-01-28 4,900 4,900 Indirect
Common Stock Stock Option (Right To Buy) $33.02 2029-01-21 26,950 26,950 Indirect
Expiration Date Amount Remaning Holdings Nature of Ownership
2020-02-02 37 37 Indirect
2022-01-10 38 38 Indirect
2021-04-27 58 58 Indirect
2026-01-03 11,000 11,000 Indirect
2025-01-02 10,880 10,880 Indirect
2024-01-28 4,900 4,900 Indirect
2029-01-21 26,950 26,950 Indirect
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person's spouse on March 13, 2019.
  2. Currently exercisable.
  3. This option was granted on November 17, 2016 and vests over four years, with 25% of the shares underlying the option vesting on November 17, 2017, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on February 17, 2018.
  4. This option was granted on January 3, 2017 and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2018.
  5. This option was granted on January 3, 2018 and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019.
  6. This option was granted on January 4, 2016, and vests over four years, with 25% of the shares underlying the option vesting on January 4, 2017, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 4, 2017.
  7. This option was granted on January 22, 2019 and vests over four years, with 25% of the shares underlying the option vesting on January 22, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning April 22, 2020.